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Abstract UCP2 is expressed in pancreatic β cells where its
postulated uncoupling activity will modulate glucose-
induced changes in ATP/ADP ratio and insulin secretion.
The consequences of UCP2 over/underexpression on β-cell
function has mainly been studied in the basal state;
however, a UCP has no uncoupling activity unless
stimulated by fatty acids and/or reactive oxygen species.
Here, UCP2 was overexpressed in INS-1 cells and
parameters reflecting mitochondrial coupling measured in
the basal state and after stimulation by fatty acids. For
comparison, UCP1 was expressed to similar levels and the
same parameters measured. Neither UCP1 expression nor
UCP2 overexpression modified basal or glucose-stimulated
metabolic changes. Upon addition of fatty acids, UCP1-
expressing cells displayed the expected mitochondrial
uncoupling effect, while UCP2 did not elicit any mea-
surable change in mitochondrial function. Taken together,
our data demonstrate that, in pancreatic β-cells, UCP2 has
no uncoupling activity in the basal state or after fatty acid
stimulation.
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Introduction
In the pancreatic β-cell, changes in ATP/ADP play a key
role in the coordinated mechanism that senses changes in
glucose metabolism and transduces its signal in insulin
secretion. The presence of UCP2 in pancreatic β-cells and
the regulation of its expression by fatty acids, PPARγ and
PPARα agonists or glucose [1–5], drew the attention on
this protein as a potential modulator of insulin secretion. Its
postulated uncoupling activity would dissipate the proton
gradient across the mitochondrial inner membrane, thereby
attenuating basal and/or glucose-induced ATP generation
and downstream effects on the closure of KATP channel,
plasma membrane depolarization, Ca2+ entry, and insulin
secretion. Studies in UCP2 KO mice [6] or in pancreatic
beta cells and cell lines overexpressing UCP2 [7, 8] have
suggested that the uncoupling activity of the protein plays
an important role in the modulation of ATP generation and
insulin secretion. Similarly, other studies correlate changes
in UCP2 expression with alterations in insulin secretion.
Sirt1 positively regulates insulin secretion and represses
UCP2 expression [9]; Foxa1 deficient islets have a decreased
ATP synthesis suggestedly explained by an increased
expression of UCP2 [10]. Pancreatic islets from type 2
diabetic subjects show increased UCP2 gene expression,
abnormal mitochondrial morphology, and impaired glucose-
stimulated insulin secretion [11]. Based on these studies, one
may conclude that, when present, UCP2 has uncoupling
properties proportional to its level and/or that an activator is
produced that induces its activity.
Other studies, however, do not support this observation:
β-cell-specific overexpression of UCP2 in transgenic mice
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neither modified basal nor glucose-stimulated insulin
secretion or changes in ATP/ADP ratio [12]. INS-1 cells
with a doxycycline-inducible overexpression of UCP2 show
no sign of uncoupling measured as change in mitochondrial
membrane potential, ATP generation, or oxygen consump-
tion, and display normal glucose-induced insulin secretion
[12]. Reversing hyperglycemia in db/db mice restored
normal glucose sensitivity in isolated islets without changes
in the high level of UCP2 mRNA [13]. Similarly, rat islets
cultured in a high glucose medium have a high mitochon-
drial metabolism and ATP production despite a 1.7-fold
increase in UCP2 mRNA [14]. Other studies in the INS-1E
cell line show that overexpression of PPARα and RXR
results in a three- to fourfold increase in the level of
UCP2 protein, without changes in the mitochondrial
membrane potential and glucose-induced insulin secretion.
The absence of uncoupling effect measured in the latter
studies means either that UCP2 will be active only if the
proper stimulant is added, or that UCP2 has no
uncoupling activity, as suggested by studies in isolated
mitochondria from other tissues expressing this protein,
naturally or ectopically [15, 16].
These conflicting data reflect the lack of consensus on
the physiological role of the “new” uncoupling proteins,
UCP2 and UCP3, and the regulation of their activity
(reviewed in [17–19]). The behavior of UCP1, the standard
uncoupling protein, depends on the condition in which it is
studied. In its cellular environment, UCP1 displays no
uncoupling activity, due to inhibitory effect of the purine
nucleotides present. Addition of fatty acids will activate the
protein by relieving this inhibition, thereby dissociating
respiration from ATP synthesis [20].
Based on the observation that: (1) in pancreatic β-cell,
an increase in UCP2 is not always accompanied by
decreased glucose-stimulated insulin secretion, (2) the
proposed uncoupling activity of the “new UCPs” in
particular is still debated, (3) UCP1, the original uncoupling
protein, needs an activator to exhibit uncoupling properties;
UCP2 was overexpressed in a pancreatic beta cell line and
several indicators of mitochondrial coupling measured in
the absence and presence of fatty acids in intact cells.
Similar experiments were performed in the same cell line
expressing UCP1 at comparable levels. The data show
that, in the basal state, neither UCP2 overexpression
nor UCP1 expression modified mitochondrial coupling.
Addition of fatty acids to activate the protein resulted in
a lowering of the mitochondrial membrane potential and
acceleration of oxygen consumption in UCP1-expressing
cells, but not in cells overexpressing UCP2. Taken
together, the data demonstrate that in intact cells,
UCP1, but not UCP2, can trigger uncoupling when
activated by fatty acids.
Materials and methods
Establishment of inducible INS-1 stable cell lines
The parental INS-1 cell line expressing the reverse
tetracycline-dependent transactivator (INS-1-r9 cells) was
kindly provided by P. Iynedjian and H. Wang. The plasmid
used for the second stable transfection was constructed by
subcloning the human UCP1 cDNA isolated from human
perirenal brown adipose tissue [21] into the expression
vector pTRE2pur. INS-1r9 stable transfection, clone selec-
tion, and screening were as described in [22] except that the
selection was performed with 1 μg/ml puromycin. Three
positive clones were obtained and one of them was used in
the present study. Establishment of the inducible cell line
expressing hUCP2 has been described previously [12].
Cell culture
The INS-1 cells were cultured in RPMI 1640 medium
containing 11 mM glucose supplemented with 5% heat-
inactivated FCS, 10 mM HEPES, 1 mM pyruvate, 50 μM
β-mercaptoethanol, 100 U/ml penicillin, and 100 μg/ml
streptomycin as described in [12].
Cells were plated into 24-well plates or in 100-mm Petri
dishes and cultured under standard conditions. After 1–
2 days, 500 ng/ml doxycycline (Sigma Chemical, St. Louis,
MO, USA) was added for 48 h to induce UCP1 or UCP2
expression. For the measurement of UCP1 and UCP2 half-
lifes, cells in 100-mm Petri dishes were or not induced with
500 ng/ml doxycycline for 48 h, then the medium was
removed and the cells incubated with fresh medium without
doxycycline, and cycloheximide (10 μg/ml) added. Cells
were collected at 0, 30, 60, 120, 180, and 360 min and
mitochondria isolated and used for Western blotting.
Insulin secretion
Cells were washed, preincubated for 60 min in KRBH
containing 2.8 mM glucose and 0.2% BSA, incubated for
30 min in the same medium with the additions mentioned,
and insulin concentration determined in the medium. Total
cellular insulin content, measured after cold acid/ethanol
extraction, and insulin secretion were quantified by radio-
immunoassay using rat insulin as standard [23]. DNA was
measured as in [24].
ATP/ADP measurements
The cells were treated as for insulin secretion, except that,
10 min after glucose addition, the medium was rapidly
removed and 0.75 ml of 0.6 M HClO4 added to the cells.
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The extract was centrifuged and an aliquot of the
supernatant neutralized with 2.7 M K2CO3. ATP was
assayed using luciferase. For ADP measurement, ATP was
first hydrolyzed to AMP using ATP sulfurylase [25]. After
inactivation of the sulfurylase, ADP was converted to ATP in
the presence of pyruvate kinase and phosphoenolpyruvate
and was measured by luciferase [1].
Mitochondrial membrane potential (ΔΨm)
Mitochondrial membrane potential was measured using
rhodamine 123 (Molecular Probes, Eugene, OR, USA).
Cells in 24-well plates were preincubated for 1 h in KRBH
containing 2.8 mM glucose, loaded with 10 μg/ml rhodamine
123 for 20 min, washed, incubated in KRBH, and transferred
to a thermostated plate reader (Fluostar Optima, BMG
Labtechnologies, Offenburg, Germany). The Δψm was
monitored with excitation and emission set of 485 and
525 nm, respectively. Glucose (12 mM final concentration),
or BSA (0.12% final concentration), or BSA-oleate (0.1 mM
final concentration) and CCCP 30 μM were added succes-
sively as described in [26].
DAPI and mitotracker staining
INS-1 cells were seeded on poly-L-ornithine-coated glass
coverslip in cell culture medium and cultured 3 days.
Mitochondria were then stained by incubation in RPMI
medium containing 500 nM mitotracker orange (CMTMRos,
Molecular Probes) for 30 min. Cells were then washed two
times and fixed in 4% para-formaldehyde for 20 min at
room temperature. Nuclei were then stained by incubation
with 5 μg/ml DAPI for 3 min. Cells were visualized by
fluorescence microscopy (Axioskop 2 equipped with an
Axiocam color CCD camera). Images were recorded and
treated through the Axiovision software (Zeiss, Germany).
Western blotting
Mitochondria were prepared from cultured cells using the
Mitochondria/Cytosol fractionation kit (BioVision Inc.,
Mountain View, CA, USA) according to the manufacturer’s
instructions. Proteins were measured using the Bio-Rad
protein assay (Bio-Rad Laboratories GmbH, München,
Germany), with BSA as standard.
Fifteen micrograms of mitochondrial proteins was sub-
jected to electrophoresis on a 12% polyacrylamide gel,
electrotransfered to Immobilon P membranes (Millipore
Corporation, Bedford, MA, USA), blocked with 2.5% Top
Block (VWR International AG, Luzern Switzerland) in
phosphate-buffered saline, 0.1% Tween, and incubated
overnight at 4°C in the same buffer containing polyclonal
antibody to UCP1 or UCP2 (6528 and 6526 for UCP1 and
UCP2 respectively, Santa Cruz Biotechnology, Santa Cruz,
CA, USA). After washing, the membranes were incubated
with a horseradish peroxidase-coupled IgG antibody
(Amersham, UK) for 1 h at room temperature. Cytochrome
oxidase and prohibitin were detected on the same mem-
brane, using a monoclonal antibody against subunit IV of
cytochrome oxidase (Molecular Probes Inc.) or prohibitin
(Research Diagnostics Inc., Flanders, USA) and horseradish
peroxidase-coupled anti-mouse IgG (Santa Cruz Biotech-
nology) as secondary antibody. The resolved bands were
visualized by UptiLight HRP blot chemiluminescent sub-
strate (Uptima, Interchim, Montluçon, France) and exposed
to Hyperfilm™ ECL™ (Amersham, UK) for 1 to 10 min.
Statistical analysis
Results are presented as mean ± SE of the indicated number
of independent experiments. Statistical analysis was per-
formed using Student’s t test. Differences were considered
significant for p<0.05.
Results
Inducible expression of UCP1 and UCP2 in INS-1 cells
To compare the consequences of similar levels of UCP1
and UCP2 on mitochondrial properties, INS-1 cells with a
doxycycline-inducible expression of UCP1 were generated
and compared to cells with inducible overexpression of
UCP2 generated as previously described [12]. Addition of
500 ng/ml doxycycline for 48 h resulted in an 11.3±1.2-
fold (±SE, n=4) increase in UCP2 (Fig. 1a). A similar
induction was used for UCP1. This resulted in comparable
levels of UCP1 and UCP2 as quantified with known
amounts of recombinant UCP1 and UCP2 (Fig. 1a,b). The
estimated concentration was between 1 and 1.5 ng uncou-
pling protein/μg protein of crude mitochondrial preparation
for both uncoupling proteins. The two uncoupling proteins
were found exclusively in the mitochondria and not in the
cytosolic fraction (data not shown). UCP1 antibody
exhibited minimal cross reactivity with UCP2 as assessed
by the very faint signal in lane 1 of Fig. 1b and c,
representing mitochondria from non-induced cells, contain-
ing UCP2. UCP2 antibody did not show any signal when
tested with recombinant UCP1 (data not shown). Expres-
sion of UCP1 did not significantly modify the level of
UCP2 (Fig. 1c). Induction of UCP2 or UCP1 did not induce
changes in amount of mitochondria, as indicated by the
constant level of two mitochondrial protein, cytochrome
oxidase (Fig. 1a–c) and prohibitin (data not shown).
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The staining pattern of the mitochondria with mito-
tracker, a mitochondrial fluorescent marker, shows no
visible difference between control and induced cells,
indicating that neither UCP2 nor UCP1 modified mito-
chondrial shape or number (Fig. 1d). Compared to UCP1,
UCP2 is known to have a very short half-life [27]. To
examine whether this is also observed in INS-1 cells, the
half-life of endogenous and endogenous plus overexpressed
UCP2 as well as that of expressed UCP1 were measured
after treatment with the translation inhibitor cycloheximide.
Figure 2 shows that both endogenous and overexpressed
UCP2 decrease rapidly after addition of 10 μg/ml cyclo-
heximide, while the level of UCP1 remained stable over the
6 h of measurement. The half-life of endogenous and of
overexpressed plus endogenous UCP2 was 94±3 (n=3) and
98±4 min (n=4), respectively.
Similar levels of UCP1 and UCP2 do not alter the basal
and glucose-induced changes in insulin secretion, ATP/
ADP ratio, or mitochondrial membrane potential (Fig. 3a–f).
Glucose-induced hyperpolarization, represented by a down-
shift of the fluorescence, was similar in control and induced
cells (Fig. 3e–f). To evaluate the possibility that UCP2 or
Fig. 1 UCP2 overexpression or
UCP1 expression in INS cells.
a Basal and doxycycline-
induced (doxy) expression of
UCP2 in INS-1 cells. For com-
parison, 20 ng of recombinant
(rec) UCP2 are shown.
b Doxycycline-induced (doxy)
expression of UCP1 in INS-1
cells. For comparison, 20 ng of
recombinant (rec) UCP1 are
shown. c Doxycycline-induced
expression of UCP1 does not
alter UCP2 level. Cells were
cultured and induced with
different concentration of
doxycycline. After 48 h, mito-
chondria were isolated, 15 μg
mitochondrial protein separated
by SDS-PAGE, and UCP2,
UCP1, and cytochrome oxidase
(COX) measured by Western
blotting as described in the
“Materials and methods” sec-
tion. d UCP2 overexpression or
UCP1 expression in INS-1 cells
does not alter mitochondrial
shape and distribution. Cells
were cultured and induced with
doxycycline to express UCP2 or
UCP1 as described in the
“Materials and methods”
section. After 48 h induction,
control and induced cells were
loaded with mitotracker, fixed,
nuclei colored with DAPI, and
the cells visualized by
fluorescence microscopy
(Axioskop 2) at 100×
magnification, bar=5 μm
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UCP1 could induce small changes in the basal mitochondrial
potential, an index of mitochondrial polarization was
calculated and expressed as the ratio (Fmax−Fbasal)/Fbasal
[28] and data from three to four independent experiments
pooled. Neither UCP2-overexpressing cells nor UCP1-
expressing cells display any significant change of this ratio
(Fig. 4g–h).
Taken together, these data indicate that neither UCP1 nor
UCP2 triggers any sign of innate uncoupling in INS-1 cells.
Fatty acids induce uncoupling in cells expressing UCP1
but not UCP2
At a cellular level, UCPs are not uncoupling unless
activated by fatty acids and/or reactive oxygen species
(ROS) [17, 20]. For this reason, oxygen consumption and
mitochondrial membrane potential were measured in cells
with similar levels of UCP2 or UCP1 before and after
addition of 0.1 mM oleate bound to 0.12% BSA (molar
ratio BSA/oleate=5.0). These experiments were performed
at 12 mM glucose, a concentration at which fatty acid
oxidation is minimal and similar in control and induced
cells (data not shown). Absolute values of oxygen
consumption were not altered by the overexpression of
UCP2: 0.182±0.016 and 0.190±0.018 nmol O2/min×μg
DNA (n=4) for control and induced cells, respectively.
Figure 4a shows that oxygen consumption is unchanged
after BSA addition and increased by 40% (p<0.05) after
addition of oleate to control cells. This increase was
unchanged by UCP2 induction. In contrast, a specific
stimulation of respiration was measured in UCP1-expressing
cells after oleate addition (Fig. 4b). As for UCP2, absolute
values of basal oxygen consumption were not altered by the
expression of UCP1: 0.189±0.009 and 0.182±0.023 nmol
O2/min×μg DNA (n=4) for control and UCP1-expressing
cells, respectively. In agreement with the fatty acid-induced
changes in oxygen consumption, addition of oleate produced
a slight decrease in the mitochondrial membrane potential
that was unaltered by UCP2 overexpression (Fig. 4c), while
this decrease was amplified by the presence of UCP1
(Fig. 4d).
Discussion
The results of the present study clearly show that, when
expressed at similar levels in pancreatic INS-1 cells, neither
UCP1 nor UCP2 affect basal mitochondrial metabolism as
indicated by the lack of effect on cellular oxygen
consumption, ATP/ADP ratio, mitochondrial membrane
potential, and indirectly by similar glucose-stimulated
insulin secretion. Upon addition of fatty acids, only the
cells with UCP1 show signs of uncoupling as evidenced by
increased oxygen consumption and decreased mitochondrial
membrane potential. Cells expressing UCP2 at comparable
levels do not respond to the addition of the fatty acid.
Previous studies have shown that the functional proper-
ties of UCP1 described in brown adipose tissue mitochon-
dria in response to fatty acids [29] are also observed when
the protein is expressed in other cell types like skeletal
muscle cells [30] or CHO cells [31]. The present study
shows that this is also the case when UCP1 is expressed in
the pancreatic β-cell line INS-1.
One of the main criticisms addressed to experiments
with overexpression of UCPs is a non-specific uncoupling
due to an artifact of supraphysiological levels of the
protein. This artifact results in an activity of the protein in
the basal state (i.e., without activation by fatty acids) that is
not inhibited by purine nucleotides when studied in isolated
Fig. 2 Half-life of UCP2 and UCP1 in INS-1 cells. Control cells and
cells overexpressing UCP2 or cells expressing UCP1 were treated
with cycloheximide (10 μg/ml) for 0, 30, 60, 120, 180, and 360 min
and UCP2 (open triangle, endogenous; black diamond, induced +
endogenous) or UCP1 (open circle) levels determined by Western
blotting and expressed as percent of initial values. Results are mean±
SD of three to four independent experiments. Inset Representative
Western blotting of endogenous, endogenous plus overexpressed
UCP2, and of induced UCP1. To see all the spots of endogenous
UCP2, the blot had to be exposed for 10 min instead of 2 min for the
other data
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mitochondria [32]. In the present study, the lack of
uncoupling in the basal conditions, indicated by similar
mitochondrial membrane potential, oxygen consumption,
and ATP/ADP ratio is an indirect indication that the
insertion of UCP1 and UCP2 in the mitochondrial mem-
brane is not causing nonspecific proton leaks. Indeed,
mammalian UCP2 expressed in yeast at a level comparable
to that reached in our study did not result in basal or fatty
Fig. 3 UCP2 overexpression or UCP1 expression in INS-1 cells does
not affect glucose-induced changes in insulin secretion, ATP/ADP
ratio, or mitochondrial membrane potential. a Insulin secretion in
response to glucose in control and UCP2-overexpressing cells. b
Insulin secretion in response to glucose in control and UCP1-
expressing cells. c Basal and glucose-induced changes in ATP/ADP
ratio in control and UCP2-overexpressing cells. d Basal and glucose-
induced changes in ATP/ADP ratio and in control and UCP1-
expressing cells. All the results are mean±SE of four to six
independent experiments performed as described in the “Materials
and methods” section. e Mitochondrial membrane potential (ΔΨm) at
2.8 mmol/l glucose (Fbasal) and 12 mmol/l glucose and after maximal
depolarization (Fmax) with 10 μmol/l CCCP in control cells and in
cells overexpressing UCP2. f Mitochondrial membrane potential
(ΔΨm) at 2.8 mmol/l glucose (Fbasal), after addition of glucose to
12 mmol/l final concentration, and at maximal depolarization (Fmax)
with 10 μmol/l CCCP in control cells and in cells expressing UCP1. g
Index of mitochondrial polarization as measured by the ratio (Fmax−
Fbasal) /Fbasal in control and UCP2-overexpressing cells. h Index of
mitochondrial polarization as measured by the ratio (Fmax−Fbasal) /
Fbasal in control and UCP1-expressing cells. For g and h, results are
mean±SE of quadruplicate measurements from three independent
experiments performed as described in the “Materials and methods”
section. White column and open circle control cells; black column and
black diamond UCP2-overexpressing cells; hatched column and black
triangle UCP1-overexpressing cells
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acid-induced uncoupling [16]. Similarly, no basal or
stimulated uncoupling was measured in UCP2-containing
mitochondria of spleen or lung, the two organs expressing
UCP2 protein at the highest level [15]. However, a proton
leak proportional to the overexpression of UCP2 was mea-
sured in mitochondria isolated from INS-1 cells [33]. The
difference between the present study and that of Fink et al.
[33] could be explained either by higher levels of UCP2 or
by the measurements in isolated mitochondria instead of
whole cells. Our results also diverge from those of Affourtit
and Brand [34]. These authors showed that a knock-down
of UCP2 in INS-1E cells recouples the mitochondria and
improves glucose-induced insulin secretion. Additional
indirect indication for similar behavior of endogenous and
overexpressed protein is provided by the equally short half-
life of UCP2 measured in mitochondria from noninduced
and induced cells. A short half-life of the protein has been
first described in lung, spleen and intestine, and in UCP2
expressed in yeast [27]. Similarly, the longer half-life of
UCP1 found in brown adipocytes [35] is also measured
when this protein is expressed in INS-1 cells.
It is now generally accepted that, within a cell, any
uncoupling protein needs an activator to increase proton
conductance; this activator can be fatty acids [36], reactive
oxygen species [37], or still undetermined molecules. Fatty
acids are known to act as weak uncouplers of mitochondrial
respiration in several cell types including hepatocytes
which neither express UCP1 nor UCP2 (reviewed in
[38]). A similar UCP-independent uncoupling effect in
pancreatic beta cells could explain the small effect of oleate
on the mitochondrial membrane potential and on oxygen
consumption in noninduced cells. Alternatively, but less
likely, the effect could suggest that the low basal level of
UCP2 is sufficient to trigger a maximal uncoupling effect
of the protein. The lack of fatty acid-induced uncoupling in
cells with increased UCP2 levels is in agreement with
studies using UCP chimera expressed in yeast and tested
for their response to fatty acids. Yeast mitochondria, with
Fig. 4 Fatty acids induce uncoupling in cells expressing UCP1 but
not UCP2. a Effects of BSA, BSA-oleate, or CCCP on oxygen
consumption in control cells and in cells overexpressing UCP2. b
Effects of BSA, BSA-oleate, or CCCP on oxygen consumption in
control cells and in cells expressing UCP1. c Effect of oleate on
mitochondrial membrane potential (ΔΨm) in control (white diamonds)
and UCP2-overexpressing cells (black diamond). d Effect of oleate on
mitochondrial membrane potential (ΔΨm) in control (white square)
and UCP1-overexpressing cells (black triangle). For a and b, cells
were cultured and doxycycline added as described in the “Materials
and methods” section. After 48-h induction, cells were detached and
oxygen consumption measured in the thermostated cuvette of a Clark-
type electrode. Basal oxygen consumption was measured at 12 mmol/
l glucose then BSA (final concentration 0.12%) or BSA-oleate (final
concentration 0.1 mM) were added, followed by 10 μM CCCP.
Results are mean±SE of at least four independent measurements. *p<
0.05 between control and UCP1-expressing cells. For c and d, cells
were cultured and doxycycline added as described in the “Materials
and methods” section. After 48-h induction, cells were loaded with
rhodamine 123 and mitochondrial potential measured before and after
oleate and CCCP addition. Results are mean±SE of quadruplicate
measurements of one representative experiment. *p<0.05 between
control and UCP1-expressing cells
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UCP1 recombinantly expressed, display a high sensitivity
to uncoupling induced by fatty acids, which is not observed
in mitochondria with UCP2 expression [39]. Using protein
chimera, this group showed that the introduction of the
central matrix loop of UCP1 into UCP2 is necessary and
sufficient to confer fatty acid-induced uncoupling. It
should however be mentioned that, when inserted in lipid
bilayers, UCP1 and UCP2 display similar fatty acid-
induced proton conductance [40]. Such discrepant con-
clusions obtained from different experimental settings
highlight the need to also study the uncoupling proteins in
their cellular environment.
The role of UCP2, its mechanism of action and
regulation, as that of the other novel uncoupling proteins,
is still under study and contradictory findings reported. The
assumption that UCP2 and UCP3 act on proton leak is
challenged by several studies (reviewed in [17]) due to the
properties of the proteins and/or to their very low degree of
expression [15, 16, 19, 41]. Other functions have been
proposed, related or not to their putative uncoupling
function and very low level of expression. In particular,
UCP2 could play a role in the control of mitochondrial
ROS production [37, 42] and cell viability [43, 44] as an
essential component of mitochondrial Ca2+ uptake [45] or
as a determinant of substrate utilization by the mitochondria
[46]. In a previous study, we showed that when cells with
increased UCP2 are exposed to cytokines, they produce less
ROS [12] and less nitric oxide (NO) [47, and Produit-
Zengaffinen (manuscript in preparation)]. The exact mecha-
nism leading to changes in ROS and NO generation is not
yet determined, but these observations can be related to the
increased level of iNOS and NO production in macro-
phages of UCP2 KO mice [48, 49] and decreased LPS-
induced iNOS expression in the macrophage cell line
RAW264 with UCP2 overexpression [50].
In summary, the present study demonstrates that an
increased level of UCP2 in pancreatic β-cells does not
induce any changes in basal and fatty acid-stimulated
mitochondrial function. When expressed at similar levels
in the same cell line, UCP1 displays the expected fatty acid-
induced uncoupling. While our data do not confirm a role
of UCP2 in the regulation of mitochondrial membrane
potential, our previous data provide evidences that UCP2
may decrease ROS production [12]. These data, together
with the short half-life of the protein and the translational
regulation of its expression [51, 52], suggest an important
function for this protein in pancreatic β cells.
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